MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Cucurbitacin I

CAS No. : 2222-07-3

MCE 站：Cucurbitacin I

产品活性：Cucurbitacin I 是 JAK2/STAT3 的天然选择性抑制剂，并具有有效的抗肿瘤活性。

研究领域：JAK/STAT Signaling  |  Stem Cell/Wnt  |  Epigenetics

作用靶点：STAT  |  JAK

In Vitro: Exposure of the COLO205 cells to Cucurbitacin I significantly decreases cell viability. The anticancer activity of Cucurbitacin I is accomplished by downregulating p-STAT3 and MMP-9 expression. PE-induced cell enlargement and upregulation of ANF and β-MHC are significantly suppressed by pretreatment of the cardiomyocytes with Cucurbitacin I. Notably, Cucurbitacin I also impaires connective tissue growth factor (CTGF) and MAPK signaling, pro-hypertrophic factors, as well as TGF-β/Smad signaling, the important contributing factors to fibrosis. Incubation of the Seax cell line with the Jak/Stat3 inhibitor Cucurbitacin I result in a time- and concentration-dependent decrease of P-Stat3 and Stat3. In freshly isolated Sz cells (n=3), Cucurbitacin I induces a concentration-dependent decrease in Stat3 expression whereas P-Stat3 is undetectable. Finally, incubation of freshly isolated Sz cells (n=4) with 30 μM Cucurbitacin I for 6 hours induces apoptosis in the large majority (73-91%) of tumor cells.

In Vivo: No major side effects are noted throughout the study. It is shown that average tumor volumes at the end of the study are as follows: control, 616 mm³ (±130); CQ, 580 mm³ (±107); Cucurbitacin I, 346mm³ (±79); and combination, 220mm³ (±62). The differences in tumor volume between the Cucurbitacin I and control, combination and control, and combination and Cucurbitacin I arms are significant. Furthermore, combination-treated tumors exhibit a significantly lower average tumor weight at study termination than the control. Moreover, there was no effect on the body weights of mice.

相关产品：Natural Product Library Plus  |  Bioactive Compound Library Plus  |  Stattic  |  AG490  |  Upadacitinib  |  Fludarabine  |  AS1517499  |  Niclosamide  |  Artesunate  |  Homoharringtonine  |  TPCA-1  |  Colivelin TFA  |  Cryptotanshi  |  Napabucasin  |  Pimozide  |  STAT5-IN-1  |  C188-9  |  AT9283  |  Gandotinib  |  Scutellarin  |  Lestaurtinib  |  BP-1-102  |  Oclacitinib maleate  |  JANEX-1  |  Saikosaponin D  |  Fraxinellone  |  Nifuroxazide  |  XL019  |  STAT3-IN-1  |  Alantolactone  |  Atractylenolide I  |  Dihydroisotanshi I

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。